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Abstract
Background: Exertional rhabdomyolysis syndrome is recognised in many athletic horse breeds and in recent years specific
forms of the syndrome have been identified. However, although Standardbred horses are used worldwide for racing, there
is a paucity of information about the epidemiological and performance-related aspects of the syndrome in this breed. The
objectives of this study therefore were to determine the incidence, risk factors and performance effects of exertional
rhabdomyolysis syndrome in Standardbred trotters and to compare the epidemiology and genetics of the syndrome with
that in other breeds.
Methodology/Principal Findings: A questionnaire-based case-control study (with analysis of online race records) was
conducted following identification of horses that were determined susceptible to exertional rhabdomyolysis (based on
serum biochemistry) from a total of 683 horses in 22 yards. Thirty six exertional rhabdomyolysis-susceptible horses were
subsequently genotyped for the skeletal muscle glycogen synthase (GYS1) mutation responsible for type 1 polysaccharide
storage myopathy. A total of 44 susceptible horses was reported, resulting in an annual incidence of 6.4 (95% CI 4.6–8.2%)
per 100 horses. Female horses were at significantly greater risk than males (odds ratio 7.1; 95% CI 2.1–23.4; p=0.001) and
nervous horses were at a greater risk than horses with calm or average temperaments (odds ratio 7.9; 95% CI 2.3–27.0;
p=0.001). Rhabdomyolysis-susceptible cases performed better from standstill starts (p=0.04) than controls and had a
higher percentage of wins (p=0.006). All exertional rhabdomyolysis-susceptible horses tested were negative for the R309H
GYS1 mutation.
Conclusions/Significance: Exertional rhabdomyolysis syndrome in Standardbred horses has a similar incidence and risk
factors to the syndrome in Thoroughbred horses. If the disorder has a genetic basis in Standardbreds, improved
performance in susceptible animals may be responsible for maintenance of the disorder in the population.
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Introduction
Equine exertional rhabdomyolysis syndrome (ERS) commonly
affects the athletic breeds, including Thoroughbred, Quarter
Horse, Arabian, Warmblood, and Standardbred [1–7]. The
intermittent syndrome is characterised by stiffness, muscle
cramping and pain and is accompanied by mild to markedly
elevated plasma activities of the muscle-derived enzymes, creatine
kinase (CK) and aspartate aminotransferase (AST). Work in recent
years has identified specific causes of ERS that may be either
acquired or inherited [5]. In the latter category, certain forms are
common within specific breeds. For example, type 1 polysaccha-
ride storage myopathy is common in Quarter Horses but not
Thoroughbreds [8,9], whereas a disorder associated with a
dominantly inherited defect in sarcoplasmic calcium regulation,
known as recurrent exertional rhabdomyolysis, is reported to
occur in Thoroughbreds but not Quarter Horses [10,11].
Epidemiological studies in specific breeds have defined the risk
factors and welfare and economic implications of ERS. For
example, between 5 and 7% of Thoroughbreds are affected
worldwide [3,12,13] with 2- and 3-year-old horses in training
being commonly affected [14]. ERS has marked economic
implications in Thoroughbreds [15] with 69% of affected animals
unable to race and typically losing 5.8 training days per disease
episode [16,17]. Several epidemiological studies in Thoroughbreds
reveal that young fillies and nervous horses have a greater ERS
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however, (most of which carry a gain of function missense
mutation (R309H) in the skeletal muscle glycogen synthase gene
(GYS1)) [9], no associations with sex, age or temperament were
found [18].
To the authors’ knowledge, there have been no epidemiological
studies of ERS in Standardbred horses even though this is a
popular racing breed in many countries. Despite this, an early
genetic association study suggested that the disorder in Standard-
bred horses may have an underlying genetic basis [19]. Given that
racehorses are selectively bred for performance, and if ERS in this
breed is indeed genetic, it would be surprising if the trait had a
deleterious influence on performance; indeed, it is conceivable that
the trait may confer certain performance advantages in a similar
manner to that of other genetic diseases of horses [20], resulting in
inadvertent maintenance of the trait in the population.
Although isolated reports exist of Standardbred horses with
polysaccharide storage myopathy [1,21], anecdotal, histopatho-
logical [22,23] and some in vitro experimental evidence [24]
suggests that ERS in Standardbreds may be similar, if not identical
to recurrent exertional rhabdomyolysis in Thoroughbred horses. If
so, then the disorders in each breed may have the same or similar
associated risk factors. As such, the aim of this study was to
investigate the hypothesis that ERS in Standardbreds has similar
risk factors to recurrent exertional rhabdomyolysis in Thorough-
breds. In addition, we hypothesised that Standardbred horses with
ERS would perform as well as, or better than matched controls in
various indices. Finally, because the genetic basis of type 1
polysaccharide storage myopathy has recently been identified, we
aimed to test a group of susceptible Standardbred horses for the
presence of the associated GYS1 mutation.
Results
Telephone survey
Of 66 Standardbred trotting trainers licensed by the Swedish
Trotting Association and contacted either via letter, email or
telephone in March 2007, 57 were willing to participate in the
study and were contacted again via telephone (Table 1). Nine were
excluded either because they did not respond to attempts to
contact them, did not want to participate or were no longer
training horses. The 57 remaining trainers had 1402 Standardbred
horses in training, ranging from 6 to 85 horses in each yard
(median 19). There were 410 stallions (29.2%), 429 geldings
(30.6%) and 563 mares (40.2%) with ages ranging from 1 to 12
years. Fifty eight out of 1402 horses were reported to have been
affected by ERS in the 12-month study period and thus the
trainer-reported annual incidence of ERS was 4.1 cases (95% CI
3.1–5.1) per 100 horses in training. Thirty five of 57 yards (61.4%)
had at least 1 horse affected; the smallest yard reporting a case had
only 9 horses in training while the largest affected yard trained 65
horses. The incidence within individual yards with at least 1 case
ranged from 1.7 (95% CI 0–6.0) to 20 (95% CI 0–44.7) cases per
100 horses over 12 months. Thirty of 57 (52.6%) trainers routinely
measured muscle enzymes for confirmation of diagnosis; 36 of 57
(63.2%) trainers considered ERS to be a significant problem in the
Standardbred breed.
Case-control study
Out of the 35 trainers reporting at least 1 case of ERS in the
previous year, 13 (37.1%) relied on clinical signs only while 22
(62.9%) routinely utilised veterinary assessment of measured serum
CK and AST activities to confirm the diagnosis. All of these 22
trainers were willing to participate in the case-control study
(Table 1). They trained 683 Standardbred horses: 180 stallions
(26.4%), 218 geldings (31.9%) and 285 mares (41.7%) with ages
ranging from 2 to 11 years (median of 5 years). The number of
horses in each yard ranged from 10 to 65 with a mean of 31.
Forty four of the 683 horses from the 22 yards were affected by
ERS over the 12-month period; therefore the overall trainer-
reported annual incidence in this study population was 6.4 cases
(95% CI 4.6–8.2) per 100 horses whilst the annual incidence in
individual yards ranged from 1.7 (95% CI 0–6.0) to 20 (95% CI 0–
44.7) cases per 100 horses. Eleven of the 22 yards reported more
than 1 case of ERS in the previous year and 28 of the 44 (63%)
affected horses had had more than 1 episode. Multiple episodes
ranged from 2 to 20 (median of 2) per horse.
History and Clinical Signs
Clinical signs included stiffness in all 44 cases, sweating in 38
(86.4%), pain or distress in 19 (43.2%), swollen or hard gluteal
muscles in 17 (22.7%) and recumbency in 2 (4%). The 44 cases
had had a total of 139 disease episodes (median of 2) in the last
year with 135 episodes (97.5%) observed within an hour after
training exercise and 2 (1.4%) episodes noticed during training.
One episode was reported just prior to a race and another was
observed just after finishing a race.
Fifteen of 44 affected horses (34.1%) had a history of lameness.
In 26 cases (59.1%) the episodes had occurred after a period of
rest, ranging from 1 to 14 days, with a median of 2; in 4 of these 26
cases (15.4%) the rest was due to another disease. Thirty three of
the 44 cases (75%) were given a day or more to recover from ERS
ranging from 1 to 28 days with a median of 7 training days lost per
episode. Twenty two of 44 cases had been prevented from racing
for between 1 and 10 weeks as a result of ERS.
Most (38 of 44; 86.4%) ERS cases were considered to be in full
fitness when the episode occurred, 4 cases (9%) were in medium
condition while 2 (4.5%) were reported as unfit. Sixteen of the 44
affected horses (36.4%) had episodes with no associated seasonality
while 9 occurred in the spring (20.5%), 6 during the summer
(13.6%), 4 in the autumn (9.1%) and 9 (20.5%) during winter
months. In 1 mare, the trainer believed that ERS was associated
with persistent oestrus in the spring, in another case it was believed
associated with a virus, while 2 horses, both stallions, were
reported to be ‘‘burnt out’’ when the episodes occurred. In other
cases no clear predisposing factor was reported.
Management
Although it was not possible to apply statistical analysis to
training and feeding practices between groups, management was
broadly similar for all horses in each yard and between yards.
Trainers fed a mean of 4.5 kg (range 3–6 kg) of concentrate and
9 kg (range 6–11 kg) roughage feed per horse.
Methods of Prevention
The 22 trainers reported various methods of preventing and
managing ERS and most yards used a combination of methods
(Table 2). Most commonly, changes in exercise regime were
reported, including not allowing a day of rest in 14 yards and
regular training in 12 yards. Many trainers (9/22) advocated
increased field turnout, with 2 using almost permanent turnout.
Six trainers emphasised the importance of mild exercise prior to
high speed training with the use of time in the field, on a vibrating
platform or on a mechanical horse walker prior to exercise.
Alterations in feeding regimes were commonly employed, with 9
trainers reducing the amount of concentrates fed when rested. Six
trainers ensured that affected horses had set daily routines while 5
trainers tried to minimize stress as much as possible. One trainer
ERS in Standardbred Horses
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to work however no trainers used dantrolene sodium or electrolyte
supplementation for prevention.
Associated Risk Factors and Performance Indicators
Descriptive statistics of continuous variables for cases and
controls are shown in Table 3. Univariable analysis indicated that
female horses were 4.3 (95% CI 1.9–9.8; p,0.001) times more
likely to have ERS than male horses, and nervous horses were 5.5
(95% CI 2.6–12.0; p,0.001) times more likely to be affected
compared to those of calm or average temperament. There was no
significant association between age and ERS (p=0.69). Of the
performance indicators investigated, only time from standstill start,
winning percentage and placing percentage were significantly
associated with ERS status: ERS horses were faster from standstill
starts (odds ratio (OR) per second increase=0.7; 95% CI 0.5–0.9;
p=0.01) and had higher winning (OR=1.04; 95% CI 1.00–1.08;
p=0.04) and placing percentage than control horses (OR=1.03;
95% CI 1.00–1.06; p=0.03). Other variables that were eligible for
consideration in a multivariable model were whether or not the
horse was unraced (p=0.10), prize money won per year of age of
the horse (p=0.06) and number of seasons raced per year of age
(p=0.15).
Results of multivariable conditional logistic regression are
shown in Table 4. Two final models were obtained that fit the
data equally well and therefore both are presented. Sex and
Table 1. General information regarding Standardbred trotters in training in 57 yards in Sweden and additional information
regarding each case and control horse in 22 yards participating in case control study.
Information obtained
Information from yards (57) in telephone survey: Number of Standardbred trotters in training
Distribution of mares, gelding and stallions
Age range of horses in training
Number of cases in the last 12 months (March 06 - Feb 07)
Use of serum muscle enzyme analysis to confirm cases
Opinion of importance of ERS to the trotting industry
Additional information from yards (22) in case control study: Methods of prevention
Feeding practices
Training regime (distance, frequency and type of work)
Use of daily turnout (hours)
Case (44) and control (88) horse information: Name
Sex (mare, gelding or stallion)
Age
Temperament (calm, average or nervous)
Additional information regarding each episode of ERS in cases: Name of the diagnosing vet
Clinical signs displayed
Use of serum muscle enzyme analysis for confirmation of ERS
Number of days off work following the episode
If the horse was prevented from racing due to ERS
Level of fitness at the time
When the episode had occurred (before, during or after training or racing)
Time of year it occurred (spring, summer, autumn, winter or throughout the year)
If the horse had been rested prior to the episode (if so, for how many days)
Number of ERS episodes within the last twelve months
If the horse had a history of lameness
Performance data* for case and control horses: Total winnings
Racing status (raced/unraced)
Number of lifetime starts
Seasons raced
Starts in each season
Best time from standstill and running start
Number of first, second and third placings
Winning and placings’ percentages
Points
*Obtained from www.travsport.se (Swedish Trotting Association website) up to and including the end of 2007. The ‘‘points’’ statistic is derived from performance in the
last 5 starts, where 1
st place gives 200, 2
nd gives 100, 3
rd gives 65, 4
th gives 25 and 5
th gives 15 points. In addition each horse is awarded 1 point for each 100 SEK earned.
doi:10.1371/journal.pone.0011594.t001
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from standstill start and either winning percentage or placing
percentage were also associated with ERS status when adjusted for
sex and temperament. When both winning percentage and placing
percentage were included in the same model (with sex,
temperament and time from standstill start), these variables
became non-significant, likely due to their strong correlation.
Other variables that were considered for inclusion in a
multivariable model became non-significant when adjusted for
sex and temperament.
Genotyping
DNA samples were available from 36 of the ERS-susceptible
Standardbred horses and all were negative for the R309H GYS1
mutation.
Discussion
This study is the first that has examined epidemiological aspects
of ERS in Standardbred horses. Results indicate that approxi-
mately 6% of horses were affected by ERS per year and that being
female and having a nervous temperament were significant risk
factors. Common regimes used to manage ERS included
alterations to diet and exercise. For certain variables, ERS-
susceptible horses performed better than matched controls.
Additional risk factors or associations were not found, perhaps
because of the relatively low number of animals studied.
The annual incidence of ERS in the telephone study (4.1%) was
lower than that reported for the case control study (6.4%) perhaps
because recognition of low grade ERS was more readily achieved
when trainers routinely measured CK and AST for diagnosis (i.e.
Table 2. Management regimes used for prevention of ERS
reported by 22 Standardbred trainers in Sweden with one or
more horses with ERS in training from March 2006- February
2007.
Approach used No of responses
No day of rest allowed 14
Regular training 12
Less concentrates fed 9
More time in field 9
Set daily routines 6
Movement before training (field, band, walker) 6
No oats fed 6
Minimise stress 5
Increased use of horse walker 4
First horse to be trained in the morning 3
Wait until CK back in normal range before train again 3
Oil supplemented in feed 3
Avoiding certain bloodlines for breeding 2
After a period of rest, gradually back into work 2
Vitamin B or Mg supplemented 2
Low dose acepromazine, when brought back into work 1
Less protein rich hay 1
Use of magnetic rugs 1
doi:10.1371/journal.pone.0011594.t002
Table 3. Descriptive statistics of continuous horse-level and performance variables for Swedish Standardbred trotters with (cases)
and without (controls) exertional rhabdomyolysis syndrome.
Variable Cases (n=44) Controls (n=88)
Mean (sd) Median (iqr) Range Mean (sd) Median (iqr) Range
Age 5.2 (2.1) 5 (4–6) 2–11 5.4 (2.1) 5 (4–7) 2–11
Time from standstill start
(seconds/km)
76.0 (1.1) 76.2 (75.4–76.6) 73.4–78.1 76.9 (2.0) 76.6 (75.7–78.1) 73.7–82.6
Time from running start
(seconds/km)
74.6 (2.0) 74.1 (72.9–76.2) 71.8–78.9 74.7 (1.9) 74.3 (73.4–75.9) 71.4–82.8
Winning % 19.9 (16.9) 16 (10–23) 0–75 15.4 (12.4) 13 (5–26) 0–56
Placing % 42.6 (19.7) 42 (32–50) 0–100 36.9 (16.8) 38 (25–46) 0–80
Points 492.1 (506.4) 345 (50–599) 0–2010 586.9 (703.5) 385 (147–681) 0–4235
Lifetime starts 32.4 (27.7) 23.5 (14–43.5) 0–130 31.0 (24.3) 24.5 (13–44.5) 1–106
Seasons raced 3.5 (1.8) 3 (2–5) 1–9 3.4 (2.1) 3 (2–5) 1–9
Total prize money won (SEK) 368,008 (390,979) 247,000 (100,000–525,856) 13,000–2,124,923 356,411 (460,059) 188,100 (46,800–423,500) 0–2,461,302
Prize money per start (SEK) 10, 927 (8,934) 7,719 (4,548–14,674) 0–38,442 10,080 (9,953) 6,691 (3,416–13,141) 0–51,623
Prize money per start per
season raced (SEK)
4,056 (4,209) 2,643 (1,228–4,945) 0–19,221 3,899 (4,657) 2,472 (1,173–4,945) 0–25,812
Prize money per season (SEK) 101,289 (87,501) 69,641 (38,500–158,605) 11,350–365,201 94,955 (104,070) 66,000 (25,600–111,250) 0– 492,260
Prize money per age of
horse (SEK)
65,869 (56,874) 47,812 (21,060– 105,177) 4,333–193,175 56,089 (69,231) 30,332 (9,118–76,243) 0–351,615
Starts per season raced 8.5 (3.9) 9 (5.8–11) 1–18.6 8.8 (3.9) 8.8 (6–11.5) 1–19.3
Seasons raced per year of age 0.6 (0.2) 0.7 (0.5–0.8) 0–1 0.5 (0.2) 0.6 (0.4–0.7) 0–0.9
sd = standard deviation; iqr = inter-quartile range.
doi:10.1371/journal.pone.0011594.t003
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similar to that reported in other breeds: 6.7% and 4.9% in UK
and USA flat racing Thoroughbreds respectively [3,13]; 6.1% in
UK National Hunt Thoroughbreds [12]; 6.7% and 9% in Polo
ponies in the UK and US respectively [25]. The registered trotting
population in Sweden consists of approximately 57,000 Standard-
breds (www.travsport.se), hence at approximately 6% incidence,
ERS in this breed likely has substantial financial and welfare
implications.
Female horses were more likely to have ERS than male horses;
this finding supports those in several other studies [3,12,13]. In
Thoroughbreds, the high female predilection may represent a
modifying influence on the presumed autosomal dominant
inheritance [26,27] although the lack of significant association of
ERS with stages of the oestrus cycle in Thoroughbreds reduces the
likelihood of a direct female sex hormone influence [28].
Standardbreds reported as having a nervous temperament were
more likely to be affected by ERS than those with an average or
calm temperament, similar to reports in Thoroughbreds [3,13]
and Polo ponies [25]. Female Thoroughbreds are reported to be
more likely to have a nervous temperament than males [29]
however, both being female and being nervous remained in each
of the final multivariable models, suggesting that each is
independently associated with ERS. The reason why ERS is most
common in nervous horses is unknown: it could either be a
consequence of the trait, or a potential cause or closely genetically
linked.
Unlike some studies in Thoroughbreds where age was a
significant risk factor [3,13], no association between age and risk
of ERS was found in Standardbreds. This may reflect differences
in management between the two racing breeds as the majority of
Standardbreds commonly enter their first race, aged 3 or 4 years
rather than as 2-year-olds for flat racing Thoroughbreds. Racing
career is also longer for Standardbreds (they commonly race until
10 and 12 years for females and males respectively). No association
of age with ERS was found in National Hunt Thoroughbred
horses (which also race at an older age) [12], or in Polo ponies
[25], or in various breeds with ERS [2].
Almost 90% of Standardbreds were considered at full fitness at
the time of their ERS episode. This contrasts findings in polo
ponies where the majority of episodes occurred after a chukka in
which the horse was perceived to be not fit enough for the level of
play demanded [25]. However, all but 2 episodes were reported to
be associated with training rather than racing which is similar to
findings in National Hunt [12] and flat racing Thoroughbreds [3],
but contrasts findings in polo ponies where competition increased
the risk of ERS [25].
Performance is a multifactorial variable likely affected by
training, level of fitness, genetics, behavior, temperament,
experience, track position, surface conditions, coach driver and
trainer. Standardbreds with ERS had a significantly faster best lap
time from a standstill start than controls, and significantly more
wins and/or placings. No significant difference was found between
groups in fastest lap time from a running start or in any other
performance indicators. Surprisingly therefore, improved perfor-
mance occurs despite an underlying susceptibility to ERS: perhaps
environmental or management effects on occasion create the
conditions necessary for an episode of rhabdomyolysis, whereas
the rest of the time, the horse is not subject to any detrimental
effects; indeed there is statistically significant enhanced perfor-
mance. Further studies are however required to determine the
reason for the faster (standing start) lap times in the affected horses,
though one conceivable explanation may be better acceleration: in
vitro studies report that muscle from Thoroughbred horses affected
by recurrent exertional rhabdomyolysis contracts and relaxes more
quickly than muscle from unaffected horses [10]. Although
acceleration and maximum speed have not knowingly been
examined in Thoroughbreds with recurrent exertional rhabdo-
myolysis, enhanced performance was not a feature of susceptible
Thoroughbreds in one study [3]. It is conceivable that enhanced
performance characteristics (i.e. faster lap time and wins) may be
responsible for the maintenance of hereditary ERS within the
Table 4. Results of multivariable conditional logistic regression analysis of variables associated with exertional rhabdomyolysis
syndrome in Swedish Standardbred trotters.
Variable Category Adjusted Odds ratio 95% Confidence interval PWald PLRS
Model 1
Sex Male 1
Female 7.1 2.1, 23.4 0.001 ,0.001
Temperament Calm or average 1
Nervous 7.9 2.3, 27.0 0.001 ,0.001
Time from standstill start (sec/km) 0.6 0.4, 1.0 0.06 0.04
Winning % 1.1 1.0, 1.1 0.008 0.006
Model 2
Sex Male 1
Female 6.4 2.0, 20.5 0.002 ,0.001
Temperament Calm or average 1
Nervous 6.6 2.2, 20.1 0.001 ,0.001
Time from standstill start (sec/km) 0.6 0.4, 1.0 0.07 0.04
Placing % 1.1 1.0, 1.1 0.003 0.001
Models were derived using a stepwise forward selection approach with variables retained in the model if they were significantly associated with ERS (PWald ,0.05) and/
or improved model fit (PLRS ,0.05). Pwald= Wald test P-value; PLRS = Likelihood Ratio Statistic P-value.
doi:10.1371/journal.pone.0011594.t004
ERS in Standardbred Horses
PLoS ONE | www.plosone.org 5 July 2010 | Volume 5 | Issue 7 | e11594Standardbred population despite the welfare implications of the
disorder and the time lost to training that we report.
Questionnaire-based studies have certain limitations. For
example, even though trainers were encouraged to elaborate
regarding disease episodes, their answers may be restricted by, and
dependent on, ability to recall information and by the questions
asked. It is conceivable that answers given in response to the
questionnaire may have been biased by prior knowledge of the risk
factors and management of the disorder in Thoroughbreds;
however, in the current study we believe that this is unlikely to be a
major factor since trainers were (for example) unaware of
recommendations to manage ERS in Thoroughbreds with
prophylactic administration of oral dantrolene [30]. Accurate
disease identification may also have been affected by failing to
recognise subclinical disease in control horses or by inaccurate or
inconsistent interpretation of muscle enzyme results.
The epidemiological profile and risk factors identified in this
study in Standardbreds are more suggestive of recurrent exertional
rhabdomyolysis in Thoroughbreds than of polysaccharide storage
myopathy in Quarter Horses, Warmblood or draught breeds
[4,9,18]. Furthermore, the muscle histopathology of ERS in
Standardbreds is reported to be similar to that in Thoroughbreds
[23] although there are 3 cases of Standardbred horses with
sarcoplasmic periodic acid schiff positive, amylase-resistant
polysaccharide inclusions [1,21], a criterion that has been used
definitively to diagnose polysaccharide storage myopathy, but that
may occasionally yield false positive results for the disorder now
known to be associated with the R309H GYS1 mutation (type 1
polysaccharide storage myopathy) [7,31]. In the horses examined,
no ERS-susceptible animals carried this specific GYS1 mutation
[8].
It is currently unknown whether all Thoroughbreds with ERS
have an identical disease, however a genetic predisposition with
autosomal dominant inheritance has been proposed in Thorough-
breds in the USA [27,32]. Given that ERS in Standardbreds is
also believed to be genetic in origin [19], the similarities between
the epidemiology and the histopathology of ERS in both breeds,
suggests that the cause of ERS-susceptibility may be identical in
both breeds, perhaps because the Standardbred breed originated
from Thoroughbred lines. Consequently, management and
prophylactic strategies used in Thoroughbreds may be successful
in Standardbreds: although requiring further study, Standardbred
horses with a susceptibility to ERS may respond favorably to oral
dantrolene administration [30] and dietary modifications similar
to those used in Thoroughbred horses [33,34].
Materials and Methods
Animal procedures in this study were conducted by licensed
veterinary surgeons with informed consent in accordance with the
Royal Veterinary College’s ethics and welfare committee regula-
tions.
Telephone survey
Data were gathered using a purpose-designed form and
comprised general information about horses in training (signal-
ment, number of cases with ERS in the last 12 months (March 06
– February 07) and the procedure used to confirm the diagnosis
(Table 1).
Case-control study
Horses with trainers who reported using serum or plasma
muscle enzyme activities (CK and AST) routinely to diagnose
cases of ERS and who had 1 or more ERS cases in the last year
were selected for inclusion in the case-control study. Of the 22
trainers who satisfied these criteria, 9 were based in southern
Sweden and these were interviewed in person while the remaining
13 were spread throughout Sweden: for these trainers a telephone
interview was conducted. All interviews were conducted by the
same person and a purpose-designed standardised questionnaire
was used for each interview (information requested is summarised
in Table 1).
Trainers listed all horses considered free from ERS within their
yards and subsequently, for each ERS case, 2 ERS-free horses
were randomly selected (Excel; Microsoft) from the list as matched
controls. For each case and control horse the age, sex and trainer-
perceived temperament (nervous, average or calm) was recorded.
Information about management in each yard was collected and for
each case, further information regarding the episode(s) of ERS was
also recorded. Performance data for case and control horses were
obtained from online records (www.travsport.se); performance
indicators that were assessed are listed in Table 1.
Statistical analysis
Case-control data were analysed using conditional logistic
regression, taking account of matching by trainer. Univariable
analysis was conducted to estimate crude odds ratios quantifying
the strength of association between horse-level and performance
variables and ERS. For initial analysis, continuous variables were
categorised based on quartiles to examine the shape of their
association with ERS. Tests for departure from linear trend were
conducted and variables modelled in continuous linear association
with ERS where appropriate. Variables with a p-value of ,0.20 in
univariable analysis were considered for inclusion in a multivar-
iable model to estimate adjusted odds ratios. A forward selection
approach was used to build the multivariable model; variables
were retained in the model if they remained significantly
associated with ERS (Wald test p-value ,0.05) and/or improved
model fit (Likelihood Ratio Test p-value ,0.05). All analyses were
conducted in Stata SE 9.2 (Statacorp LLP, College Station, Texas)
and the level of statistical significance was set at p,0.05.
Genotyping
Blood samples derived from jugular venipuncture from 36
Standardbred horses identified in the study as being susceptible to
ERS on the basis of routine measurement of CK and AST activity
were stored in EDTA-tubes (Vacutainer) at 220C and shipped on
dry ice. DNA was extracted from whole blood using a specific kit
(DNeasy; Qiagen UK Ltd) and the DNA was tested for the
presence of the GYS1 R309H mutation using the restriction
fragment polymorphism assay as reported previously [8]. DNA
samples from known positive and negative horses [7] were
included as controls.
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